Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$133.10

-0.35 (-0.26%)

10:53
10/07/16
10/07
10:53
10/07/16
10:53

Goldman says marijuana-derived drug maker GW Pharma 'set to fly high'

In a note to investors this morning, Goldman Sachs analyst Salveen Richter initiated GW Pharmaceuticals (GWPH) with a Buy rating, as he expects a "solid" launch trajectory for the company's lead asset Epidiolex. Earlier this week, his peer at Leerink resumed coverage of the stock with a Buy-equivalent rating, citing also the potential uptake trajectory of its investigational drug. BACKGROUND: GW Pharmaceuticals is a pre-commercial-stage biopharmaceutical company focused on cannabis-based therapies in central nervous system disorders. Its lead asset is Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies. 'SOLID' LAUNCH, UPCOMING CATALYSTS: Goldman Sachs' Richter initiated coverage of GW Pharmaceuticals with a Buy rating, saying it is "set to fly high." The analyst told investors that he expects a "solid" launch trajectory for the company's lead asset Epidiolex, and is modeling $1.6B in world-wide sales. Further, Richter sees GW Pharmaceuticals' shares trading higher on upcoming pipeline catalysts, including the publication of Epidiolex Phase 3 study data in Dravet syndrome in a top-tier medical journal in the fourth quarter, the American Epilepsy Society meeting, and the initiation of an Epidiolex Phase 3 study in infantile spasms in the fourth quarter, among a number of other events. GW Pharmaceuticals should submit the U.S. regulatory filing for Epidiolex in Dravet Syndrome and Lennox-Gastaut Syndrome in the first half of 2017, he noted, adding that he expects U.S. and EU launches in the second or third quarter of 2018. The analyst has a $189 price target on the shares. UPTAKE DRUG TRAJECTORY: On Tuesday, Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target, saying he is "highly positive" on the potential uptake trajectory of Epidiolex, now that its approval appears mostly de-risked after three successful Phase 3 trials in Dravet Syndrome and Lennox Gastaut. Moreover, the analyst sees multiple points of optimism regarding a GW Pharmaceuticals-led global launch, including strong clinical profile and "hype" surrounding Epidiolex, significant level of unmet medical need in Dravet Syndrome and Lennox Gastaut and refractory seizures, a small subset of core prescribers, and the experience of CCO Julian Gangoli. PRICE ACTION: In morning trading, shares of GW Pharmaceuticals have slipped about 1% to $131.90.

GWPH GW Pharmaceuticals
$133.10

-0.35 (-0.26%)

10/04/16
LEER
10/04/16
INITIATION
Target $162
LEER
Outperform
GW Pharmaceuticals reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target.
10/07/16
GSCO
10/07/16
INITIATION
Target $189
GSCO
Buy
GW Pharmaceuticals initiated with a Buy at Goldman
Goldman analyst Salveen Richter initiated GW Pharmaceuticals with a Buy saying he expects a solid launch trajectory for lead assets Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies, and is modeling $1.6B in world-wide sales. Richter has a $189 price target on shares based on a blend of discounted cash flow for $161 per shares and M&A value of $349 per share.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/07/16
10/07/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zillow (ZG, Z) initiated with a Buy at Needham. 2. AMD (AMD) initiated with an Equal Weight at Barclays. 3. Aflac (AFL) was initiated with an Underperform at Credit Suisse while the firm also initiated Prudential (PRU) and Assurant (AIZ) with a Neutral. 4. Fifth Third (FITB) initiated with a Neutral at Wedbush. 5. GW Pharmaceuticals (GWPH) initiated with a Buy at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

10:55
01/18/18
01/18
10:55
01/18/18
10:55
General news
Euro$ interest rate futures are again lower »

Euro$ interest rate…

NFLX

Netflix

$217.50

-4.03 (-1.82%)

, AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

10:55
01/18/18
01/18
10:55
01/18/18
10:55
Conference/Events
Wedbush digital media analyst hosts a luncheon meeting »

Digital Media Analyst…

NFLX

Netflix

$217.50

-4.03 (-1.82%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

FB

Facebook

$177.60

-0.79 (-0.44%)

TWX

Time Warner

$92.15

-0.02 (-0.02%)

DIS

Disney

$111.37

-0.6 (-0.54%)

FOXA

21st Century Fox

$37.11

0.82 (2.26%)

ROKU

Roku

$41.54

2.35 (6.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

AAL

American Airlines

$58.16

0.18 (0.31%)

10:53
01/18/18
01/18
10:53
01/18/18
10:53
Hot Stocks
American Airlines expands network in 2018, introduces new shuttle »

American recently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

LGND

Ligand

$149.33

2.94 (2.01%)

10:49
01/18/18
01/18
10:49
01/18/18
10:49
Periodicals
Breaking Periodicals news story on Ligand »

Ligand moves higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UCTT

Ultra Clean

$24.98

1.32 (5.58%)

10:48
01/18/18
01/18
10:48
01/18/18
10:48
Upgrade
Ultra Clean rating change  »

Follow-up: Ultra Clean…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

T

AT&T

$37.05

0.2 (0.54%)

, ARW

Arrow Electronics

$84.26

0.43 (0.51%)

10:46
01/18/18
01/18
10:46
01/18/18
10:46
Hot Stocks
AT&T, Arrow Electronics announce IoT collaboration »

Arrow Electronics (ARW)…

T

AT&T

$37.05

0.2 (0.54%)

ARW

Arrow Electronics

$84.26

0.43 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

QD

Qudian

$12.29

0.1 (0.82%)

10:45
01/18/18
01/18
10:45
01/18/18
10:45
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

Week of 1/12 EIA…

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
01/18/18
01/18
10:45
01/18/18
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

CAT

Caterpillar

$168.90

0.4 (0.24%)

, ROSE

Rosehill Resources

$7.96

0.01 (0.13%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CAT

Caterpillar

$168.90

0.4 (0.24%)

ROSE

Rosehill Resources

$7.96

0.01 (0.13%)

ARNA

Arena Pharmaceuticals

$34.36

0.48 (1.42%)

EA

Electronic Arts

$113.14

1.22 (1.09%)

ATVI

Activision Blizzard

$70.36

1.65 (2.40%)

BBU

Brookfield Business Partners

$36.62

-0.18 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 08

    Feb

  • 12

    Feb

  • 21

    Feb

  • 22

    Feb

SYMC

Symantec

$27.52

-0.35 (-1.26%)

, JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

SYMC

Symantec

$27.52

-0.35 (-1.26%)

JUNO

Juno Therapeutics

$69.25

23.65 (51.86%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

FSLR

First Solar

$72.00

0.78 (1.10%)

CVX

Chevron

$131.82

-0.54 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 26

    Feb

WMT

Walmart

$103.89

1.19 (1.16%)

, HTZ

Hertz

$22.39

1.33 (6.32%)

10:39
01/18/18
01/18
10:39
01/18/18
10:39
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

WMT

Walmart

$103.89

1.19 (1.16%)

HTZ

Hertz

$22.39

1.33 (6.32%)

ALRM

Alarm.com

$38.27

1.26 (3.40%)

PPL

PPL Corp.

$31.80

0.23 (0.73%)

FLR

Fluor

$59.27

1.14 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 27

    Feb

  • 16

    May

EXAS

Exact Sciences

$47.68

-5.27 (-9.95%)

10:38
01/18/18
01/18
10:38
01/18/18
10:38
Conference/Events
Exact Sciences management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 26

    Feb

UCTT

Ultra Clean

$24.98

1.32 (5.58%)

10:36
01/18/18
01/18
10:36
01/18/18
10:36
Upgrade
Ultra Clean rating change  »

Ultra Clean upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

BHP

BHP Billiton

$49.15

-0.29 (-0.59%)

10:35
01/18/18
01/18
10:35
01/18/18
10:35
Hot Stocks
BHP Billiton considers options for U.S. shale unit »

In an operational review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$21.19

-1.095 (-4.91%)

10:35
01/18/18
01/18
10:35
01/18/18
10:35
Options
Mallinckrodt put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 08

    Mar

TOL

Toll Brothers

$52.28

0.21 (0.40%)

10:34
01/18/18
01/18
10:34
01/18/18
10:34
Conference/Events
Toll Brothers management to meet with MKM Partners »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

EXEL

Exelixis

$27.49

-2.16 (-7.29%)

, IPSEY

Ipsen

$34.14

2.95 (9.46%)

10:31
01/18/18
01/18
10:31
01/18/18
10:31
Conference/Events
Exelixis and Ipsen co-host a financial community briefing »

Exelixis and Ipsen…

EXEL

Exelixis

$27.49

-2.16 (-7.29%)

IPSEY

Ipsen

$34.14

2.95 (9.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 19

    Jan

  • 19

    Jan

  • 25

    Jan

  • 08

    Feb

  • 15

    Feb

10:30
01/18/18
01/18
10:30
01/18/18
10:30
General news
EIA natural gas storage change for week ending January 12 »

Gas inventories 183 Bcf…

TIVO

TiVo

$14.50

0.1 (0.69%)

, GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

10:26
01/18/18
01/18
10:26
01/18/18
10:26
Hot Stocks
TiVo rises amid expanded patent license agreement with Google »

Shares of TiVo (TIVO) are…

TIVO

TiVo

$14.50

0.1 (0.69%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

T

AT&T

$37.33

0.48 (1.30%)

SNE

Sony

$49.09

-0.73 (-1.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

SNAP

Snap

$13.84

0.315 (2.33%)

, FB

Facebook

$177.60

-0.79 (-0.44%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
SunTrust Internet & digital media analyst holds analyst/industry conference call »

Internet & Digital…

SNAP

Snap

$13.84

0.315 (2.33%)

FB

Facebook

$177.60

-0.79 (-0.44%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

TWTR

Twitter

$23.90

-0.66 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

  • 18

    Mar

DIS

Disney

$111.57

-0.4 (-0.36%)

, VIA

Viacom

$37.85

0.95 (2.57%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media Analyst Routh,…

DIS

Disney

$111.57

-0.4 (-0.36%)

VIA

Viacom

$37.85

0.95 (2.57%)

TWX

Time Warner

$92.36

0.1916 (0.21%)

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

SPB

Spectrum Brands

$123.47

-1.69 (-1.35%)

DISH

Dish

$45.45

-2.54 (-5.29%)

NFLX

Netflix

$217.50

-4.03 (-1.82%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 22

    Jan

  • 24

    Jan

  • 30

    Jan

  • 30

    Jan

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

  • 18

    Mar

MDXG

MiMedx

$14.09

0.15 (1.08%)

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
MiMedx to hold a conference call »

Chairman & CEO Petit,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

10:25
01/18/18
01/18
10:25
01/18/18
10:25
Conference/Events
Morgan Stanley healthcare analysts hold an analyst/industry conference call »

Healthcare Analyst…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.